Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase

High density lipoprotein as a protective factor against coronary heart disease

Tavia Gordon, William P. Castelli, Marthana C. Hjortland et al. · The American Journal of Medicine · 1977 · 5.1K citations

High Density, Protective Factor, Cardiovascular Disease +12

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

David S. Celermajer, Keld E. Sørensen, Vanda M. Gooch et al. · The Lancet · 1992 · 4.7K citations · Full text

Vascular Disease, Cardiovascular Epidemiology, Cardiovascular Disease +11

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Philip J. Barter, Mark J. Caulfield, Mats Eriksson et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Gregory G. Schwartz, Anders Olsson, Markus Abt et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

Amit Khera, Marina Cuchel, Margarita de la Llera-Moya et al. · New England Journal of Medicine · 2011 · 1.9K citations · Full text